FABP2
Basic information
Region (hg38): 4:119317250-119322138
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FABP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 4 | ||||
non coding | 13 | 13 | ||||
Total | 0 | 0 | 6 | 2 | 16 |
Variants in FABP2
This is a list of pathogenic ClinVar variants found in the FABP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-119318789-C-T | Benign (Nov 11, 2018) | |||
4-119318976-T-C | Benign (Nov 11, 2018) | |||
4-119319026-C-T | Benign (Jun 20, 2021) | |||
4-119319083-T-C | Benign (Nov 11, 2018) | |||
4-119319567-A-G | not specified | Uncertain significance (May 27, 2022) | ||
4-119319580-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
4-119319598-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
4-119319612-A-C | not specified | Uncertain significance (May 13, 2024) | ||
4-119319639-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
4-119319647-CATA-C | Benign (Jun 09, 2021) | |||
4-119319647-C-CATA | Benign (Jun 09, 2021) | |||
4-119319647-C-CATAATAATA | Benign (Jun 09, 2021) | |||
4-119319647-C-CATAATAATAATA | Benign (Jun 10, 2021) | |||
4-119319779-T-C | Benign (Nov 11, 2018) | |||
4-119320491-A-G | Benign (Nov 11, 2018) | |||
4-119320504-T-C | Benign (Nov 11, 2018) | |||
4-119320519-C-T | Benign (Nov 11, 2018) | |||
4-119320570-C-A | Benign (Nov 11, 2018) | |||
4-119320694-A-G | Benign (Nov 11, 2018) | |||
4-119320696-T-A | not specified | Uncertain significance (Mar 25, 2024) | ||
4-119320747-T-C | FABP2 POLYMORPHISM | Benign (Nov 11, 2018) | ||
4-119320763-T-G | Likely benign (Oct 01, 2022) | |||
4-119320776-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
4-119320783-G-C | not specified | Uncertain significance (May 01, 2024) | ||
4-119320786-T-A | not specified | Uncertain significance (Sep 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FABP2 | protein_coding | protein_coding | ENST00000274024 | 4 | 5141 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00498 | 0.712 | 125522 | 0 | 6 | 125528 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.712 | 52 | 68.6 | 0.758 | 0.00000354 | 866 |
Missense in Polyphen | 12 | 18.688 | 0.64211 | 229 | ||
Synonymous | 0.130 | 23 | 23.8 | 0.966 | 0.00000132 | 231 |
Loss of Function | 0.731 | 4 | 5.92 | 0.676 | 3.16e-7 | 70 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000561 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000449 | 0.0000440 |
Middle Eastern | 0.0000561 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: FABP are thought to play a role in the intracellular transport of long-chain fatty acids and their acyl-CoA esters. FABP2 is probably involved in triglyceride-rich lipoprotein synthesis. Binds saturated long-chain fatty acids with a high affinity, but binds with a lower affinity to unsaturated long- chain fatty acids. FABP2 may also help maintain energy homeostasis by functioning as a lipid sensor.;
- Pathway
- Fat digestion and absorption - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);PPAR signaling pathway;Metabolism of lipids;Metabolism;Triglyceride catabolism;Triglyceride metabolism
(Consensus)
Recessive Scores
- pRec
- 0.298
Intolerance Scores
- loftool
- 0.779
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.64
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0868
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fabp2
- Phenotype
- homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; renal/urinary system phenotype; liver/biliary system phenotype;
Gene ontology
- Biological process
- triglyceride catabolic process;intestinal lipid absorption
- Cellular component
- cytosol
- Molecular function
- fatty acid binding;protein binding;long-chain fatty acid binding